(0.05%) 5 519.50 points
(0.09%) 39 879 points
(0.16%) 19 782 points
(0.01%) $81.64
(0.46%) $2.82
(-0.33%) $2 336.70
(-0.05%) $29.51
(0.27%) $1 004.50
(0.01%) $0.932
(0.02%) $10.54
(0.01%) $0.788
(-0.88%) $87.23
-3.03% $ 2.24
Live Chart Being Loaded With Signals
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer\'s disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers...
Stats | |
---|---|
Dzisiejszy wolumen | 412 961 |
Średni wolumen | 283 762 |
Kapitalizacja rynkowa | 134.58M |
EPS | $-0.250 ( Q1 | 2024-05-14 ) |
Następna data zysków | ( $-0.280 ) 2024-08-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.13 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (0.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-10 | Ra Capital Management, L.p. | Buy | 25 000 | Stock Option (Right to Buy) |
2024-06-10 | Ives Jeffrey L. | Buy | 25 000 | Stock Option (right to buy) |
2024-06-10 | Stoppel Laura | Buy | 25 000 | Stock Option (right to buy) |
2024-06-10 | Stalfort John A Iii | Buy | 25 000 | Stock Option (right to buy) |
2024-06-10 | Porter Derrell | Buy | 25 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
96.36 |
Last 95 transactions |
Buy: 19 201 615 | Sell: 5 067 478 |
Wolumen Korelacja
Acumen Pharmaceuticals, Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
OZEM | 1 |
BULD | 0.927 |
FJPNX | 0.927 |
BUFMX | 0.925 |
ATLCZ | 0.925 |
HIMGX | 0.925 |
LBRDP | 0.92 |
FEPI | 0.916 |
IMPAX | 0.915 |
BMDIX | 0.911 |
10 Najbardziej negatywne korelacje | |
---|---|
HDL | -0.943 |
BKHAU | -0.925 |
SARK | -0.901 |
NEWZ | -0.891 |
BWAQR | -0.856 |
OPTXW | -0.837 |
AMDS | -0.836 |
PTIXW | -0.836 |
GECCI | -0.834 |
CCSB | -0.833 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Acumen Pharmaceuticals, Korelacja - Waluta/Towar
Acumen Pharmaceuticals, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-184 000 (0.00 %) |
EPS: | $-1.080 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-184 000 (0.00 %) |
EPS: | $-1.080 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-169 000 (0.00 %) |
EPS: | $-1.000 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.51 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Acumen Pharmaceuticals,
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer\'s disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej